Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Melanoma 114 Carcinoma, Non-Small-Cell Lung 34 Neoplasms 26 Neoplasm Metastasis 19 Prostatic Neoplasms 18 Uveal Melanoma 16 Carcinoma, Renal Cell 16 Lung Neoplasms 14 Pancreatic Neoplasms 13 Diabetes Mellitus, Insulin-Dependent, 12 12 Small Cell Lung Carcinoma 11 Colorectal Neoplasms 10 Carcinoma, Hepatocellular 9 Uterine Cervical Neoplasms 8 Squamous Cell Carcinoma of Head and Neck 8 Breast Neoplasms 8 Sarcoma 7 Carcinoma, Transitional Cell 7 Brain Neoplasms 7 Stomach Neoplasms 6 Mesothelioma 6 Kidney Neoplasms 6 Head and Neck Neoplasms 6 Advanced Cancer 6 Urinary Bladder Neoplasms 5 Recurrence 5 Ovarian Neoplasms 5 Lymphoma, Non-Hodgkin 5 Lymphoma 5 Leukemia, Myeloid, Acute 5

Interventions

Oxaliplatin 5 Capecitabine 5 Cisplatin 4 Paclitaxel 3 Fluorouracil 3 camrelizumab 2 apatinib 2 S 1 (combination) 2 Leucovorin 2 Docetaxel 2 titanium silicide 1 rucaparib 1 relatlimab 1 pazopanib 1 linrodostat 1 ezogabine 1 endostar protein 1 dacomitinib 1 capivasertib 1 Sunitinib 1 Nivolumab 1 Metabolic Networks and Pathways 1 Irinotecan 1 Ipilimumab 1 Everolimus 1 Epirubicin 1 Electroporation 1 Drug Therapy, Combination 1 Drug Therapy 1 Congresses as Topic 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Advanced Gastric Cancer × Ipilimumab × Clear all

NCT02935634 2023-06-09

FRACTION-GC

Bristol-Myers Squibb

Phase 2 Completed

190 enrolled 25 charts

Gastrointestinal

Advanced Gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡